- $15.02bn
- $25.24bn
- $28.82bn
- 33
- 55
- 64
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,821 | 9,093 | 26,989 | 31,543 | 28,823 |
Cost of Revenue | |||||
Gross Profit | 2,518 | 2,553 | 6,507 | 4,097 | 2,297 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8,690 | 8,015 | 23,725 | 29,525 | 28,432 |
Operating Profit | 1,131 | 1,078 | 3,264 | 2,018 | 391 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 786 | 761 | 2,859 | 1,663 | -213 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,120 | 510 | 2,187 | 1,221 | -202 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 4,438 | 510 | 2,187 | 1,221 | -202 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4,438 | 510 | 2,187 | 1,221 | -256 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 16 | 2.39 | 10.4 | 5.81 | -5.23 |
Dividends per Share |